These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34454297)

  • 1. Rim enhancement on hepatobiliary phase of pre-treatment 3.0 T MRI: A potential marker for early chemotherapy response in colorectal liver metastases treated with XELOX.
    Wang X; Wang Y; Zhang Z; Zhou M; Zhou X; Zhao H; Xing J; Zhou Y
    Eur J Radiol; 2021 Oct; 143():109887. PubMed ID: 34454297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative and quantitative parameters on hepatobiliary phase of gadoxetic acid-enhanced MR imaging for predicting pathological response to preoperative systemic therapy in colorectal liver metastases.
    Gu XL; Cui Y; Wang K; Xing Q; Li XT; Zhu HT; Li ZW; Sun YS
    Eur J Radiol; 2022 Dec; 157():110572. PubMed ID: 36327859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging.
    Cui E; Long W; Luo L; Hu M; Huang L; Chen X
    Acta Radiol; 2017 Oct; 58(10):1174-1181. PubMed ID: 28090793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical uptake of Gd-EOB-DTPA on the hepatobiliary phase in the evaluation of hepatic metastasis from breast cancer: is the "target sign" a common finding?
    Ha S; Lee CH; Kim BH; Park YS; Lee J; Choi JW; Kim KA; Park CM
    Magn Reson Imaging; 2012 Oct; 30(8):1083-90. PubMed ID: 22578929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
    Chen CY; Chen J; Xia CC; Huang ZX; Song B
    J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Nondefect" of arterial enhancing rim on hepatobiliary phase in 3.0-T gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced liver magnetic resonance imaging: distinguishing hepatic abscess from metastasis.
    Choi SH; Lee CH; Kim BH; Lee J; Choi JW; Park YS; Kim KA; Park CM
    J Comput Assist Tomogr; 2013; 37(6):849-55. PubMed ID: 24270105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA "uptake" on the hepatobiliary phase of MR imaging.
    Granata V; Catalano O; Fusco R; Tatangelo F; Rega D; Nasti G; Avallone A; Piccirillo M; Izzo F; Petrillo A
    Abdom Imaging; 2015 Oct; 40(7):2364-71. PubMed ID: 26105523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The predictive value of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid enhanced MRI imaging features combined with quantitative parameters for the pathologic grading of hepatocellular carcinoma].
    Hu MJ; Yu YX; Fan YF; Jiang YM; Hu S; Wang XM; Hu CH
    Zhonghua Yi Xue Za Zhi; 2020 May; 100(17):1299-1304. PubMed ID: 32375436
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatobiliary phase enhancement of liver metastases on gadoxetic acid MRI: assessment of frequency and patterns.
    Bhayana R; Baliyan V; Kordbacheh H; Kambadakone A
    Eur Radiol; 2021 Mar; 31(3):1359-1366. PubMed ID: 32886204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of hepatobiliary phase images in Gd-EOB-DTPA-enhanced MRI of breast cancer hepatic metastasis to predict response to chemotherapy.
    Lee HJ; Lee CH; Kim JW; Park YS; Lee J; Kim KA
    Clin Imaging; 2017; 43():127-131. PubMed ID: 28314197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.
    Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Kamimura K; Nakajo M
    World J Gastroenterol; 2012 Nov; 18(43):6269-76. PubMed ID: 23180948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
    Hayoz R; Vietti-Violi N; Duran R; Knebel JF; Ledoux JB; Dromain C
    Eur Radiol; 2020 Dec; 30(12):6593-6602. PubMed ID: 32601948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.
    Tani K; Shindoh J; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    J Surg Oncol; 2018 Feb; 117(2):191-197. PubMed ID: 28876456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of contrast-enhanced intraoperative ultrasound in identifying disappearing liver metastases from colorectal carcinoma after chemotherapy.
    Arita J; Ono Y; Takahashi M; Inoue Y; Takahashi Y; Saiura A
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S390-7. PubMed ID: 24570378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of high-stage liver fibrosis using ADC value on diffusion-weighted imaging and quantitative enhancement ratio at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI at 1.5 T.
    Harada TL; Saito K; Araki Y; Matsubayashi J; Nagao T; Sugimoto K; Tokuuye K
    Acta Radiol; 2018 May; 59(5):509-516. PubMed ID: 28853292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline hepatobiliary MRI for predicting chemotherapeutic response and prognosis in initially unresectable colorectal cancer liver metastases.
    Chen Y; Lu T; Zhang Y; Li H; Xu J; Li M
    Abdom Radiol (NY); 2024 Aug; 49(8):2585-2594. PubMed ID: 39034308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI Findings of Liver Parenchyma Peripheral to Colorectal Liver Metastasis: A Potential Predictor of Long-term Prognosis.
    Nakai Y; Gonoi W; Kurokawa R; Nishioka Y; Abe H; Arita J; Ushiku T; Hasegawa K; Abe O
    Radiology; 2020 Dec; 297(3):584-594. PubMed ID: 33021892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis.
    Suh CH; Kim KW; Kim GY; Shin YM; Kim PN; Park SH
    Eur Radiol; 2015 Apr; 25(4):950-60. PubMed ID: 25537979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.
    Kim SS; Kim SH; Song KD; Choi SY; Heo NH
    J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia.
    Vanhooymissen IJSML; Thomeer MG; Braun LMM; Gest B; van Koeverden S; Willemssen FE; Hunink M; De Man RA; Ijzermans JN; Dwarkasing RS
    J Magn Reson Imaging; 2019 Mar; 49(3):700-710. PubMed ID: 30252977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.